Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

PASGPassage BIO, Inc.

Nasdaq · CIK 0001787297
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts212

Identity from submissions API

NamePassage BIO, Inc.
CIK0001787297
TickersPASG
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN822729751
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone2678660312
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
ONE COMMERCE SQUARE
2005 MARKET STREET, 39TH FLOOR
PHILADELPHIA
PA
19103
PA
Mailing address
ONE COMMERCE SQUARE
2005 MARKET STREET, 39TH FLOOR
PHILADELPHIA
PA
19103
PA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

447 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 8-K 8-K 8.01,9.01 0001140361-26-044947 001-39231 261576159 34 1892218 1 1
2026-11-19 8-K 8-K 7.01,9.01 0001140361-26-044811 001-39231 261572312 34 183900 1 1
2026-11-18 8-K 8-K 3.01 0001140361-26-044734 001-39231 261570687 34 153741 1 1
2026-11-10 10-Q 10-Q 0001104659-26-124783 001-39231 261537935 34 5752174 1 1
2026-11-06 8-K 8-K 5.02,5.07,9.01 0001140361-26-042222 001-39231 261529185 34 246466 1 1
2026-10-09 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003198 333-297601 261454224 33 1809
2026-10-09 424B3 424B3 0001140361-26-039280 333-297601 261453417 33 17314598
2026-10-08 S-4/A S-4/A 0001140361-26-039151 333-297601 261450446 33 17501160
2026-10-05 S-4/A S-4/A 0001140361-26-038646 333-297601 261441196 33 17377238
2026-09-21 S-4/A S-4/A 0001140361-26-037256 333-297601 261394799 33 17892814
2026-09-03 S-4/A S-4A 0001140361-26-035517 333-297601 261356547 33 36599124 1 1
2026-09-03 425 425 0001140361-26-035516 001-39231 261356541 34 2761206
2026-09-03 8-K 8-K 1.01,3.02,9.01 0001140361-26-035515 001-39231 261356538 34 3278882 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-003492 005-91451 261281200 34 10343
2026-08-10 10-Q 10-Q 0001104659-26-093021 001-39231 261256191 34 5779223 1 1
2026-07-22 425 425 0001140361-26-029196 001-39231 261191554 34 15427435
2026-07-21 S-4 S-4 0001140361-26-029162 333-297601 261191135 33 37142787 1 1
2026-07-02 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0000902664-26-003000 005-91451 261153934 34 30580
2026-06-29 4 xslF345X06/ownership.xml 0000902664-26-002945 8179
2026-06-25 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001957912-26-000025 005-91451 261123440 34 17804
2026-06-24 425 425 0001104659-26-077350 001-39231 261116787 34 36570
2026-06-24 425 425 0001104659-26-077312 001-39231 261116055 34 12018732
2026-06-24 8-K FORM 8-K 1.01,1.02,3.02,5.01,5.02,7.01,8.01,9.01 0001104659-26-077306 001-39231 261116034 34 12543686 1 1
2026-05-27 8-K 8-K 1.02 0001104659-26-066956 001-39231 261026355 34 148660 1 1
2026-05-26 8-K FORM 8-K 5.07 0001104659-26-065991 001-39231 261015918 34 208969 1 1
2026-05-21 4 xslF345X06/form4-05212026_080510.xml 0001986720-26-000002 5730
2026-05-21 4 xslF345X06/form4-05212026_080536.xml 0001706400-26-000002 5743
2026-05-21 4 xslF345X06/form4-05212026_080558.xml 0001303811-26-000002 5746
2026-05-21 4 xslF345X06/form4-05212026_080513.xml 0001677141-26-000006 5706
2026-05-21 4 xslF345X06/form4-05212026_080523.xml 0001280044-26-000002 5704
2026-05-21 4 xslF345X06/form4-05212026_080534.xml 0001571469-26-000002 5745
2026-05-12 10-Q 10-Q 0001104659-26-058987 001-39231 26965815 34 5322254 1 1
2026-04-28 8-K FORM 8-K 2.05 0001104659-26-049755 001-39231 26903071 34 193902 1 1
2026-04-20 8-K FORM 8-K 7.01,9.01 0001104659-26-045219 001-39231 26873348 34 6241018 1 1
2026-04-07 ARS ARS 0001104659-26-040132 001-39231 26842890 34 26288010
2026-04-07 DEFA14A DEFA14A 0001104659-26-040131 001-39231 26842889 34 373104
2026-04-07 DEF 14A DEF 14A 0001104659-26-040130 001-39231 26842884 34 2395529 1 1
2026-03-18 4 xslF345X06/form4-03182026_080313.xml 0001987062-26-000002 5604
2026-03-18 4 xslF345X06/form4-03182026_080328.xml 0001949693-26-000002 12064
2026-03-10 8-K FORM 8-K 1.02 0001104659-26-025550 001-39231 26737188 34 192273 1 1
2026-03-04 S-8 FORM S-8 0001104659-26-023445 333-294006 26721153 33 211470 1 1
2026-03-03 10-K 10-K 0001104659-26-022549 001-39231 26711040 34 10963979 1 1
2026-03-03 8-K 8-K 2.02,7.01,9.01 0001104659-26-022539 001-39231 26710992 34 6225105 1 1
2026-01-12 4 xslF345X05/form4-01122026_090148.xml 0001949693-26-000001 9976
2026-01-12 4 xslF345X05/form4-01122026_090110.xml 0001987062-26-000001 9939
2026-01-12 8-K FORM 8-K 2.02,7.01,9.01 0001104659-26-002696 001-39231 26524625 34 20719137 1 1
2026-01-09 144 xsl144X01/primary_doc.xml 0001970051-26-000002 001-39231 26523042 33 4709
2025-12-29 4 xslF345X05/form4-12292025_091215.xml 0001987062-25-000002 5762
2025-12-29 4 xslF345X05/form4-12292025_091229.xml 0001949693-25-000002 5745
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004968 005-91451 251484303 34 10631
2025-11-10 10-Q 10-Q 0001104659-25-109180 001-39231 251466734 34 7579014 1 1
2025-11-10 8-K 8-K 2.02,7.01,9.01 0001104659-25-109158 001-39231 251466419 34 6386565 1 1
2025-09-18 8-K FORM 8-K 5.02 0001104659-25-091288 001-39231 251323841 34 193466 1 1
2025-09-15 4 xslF345X05/ownership.xml 0000902664-25-004079 12238
2025-08-12 10-Q 10-Q 0001558370-25-011146 001-39231 251204010 34 7651556 1 1
2025-08-12 8-K 8-K 2.02,7.01,9.01 0001558370-25-011143 001-39231 251203982 34 5128598 1 1
2025-07-29 8-K FORM 8-K 8.01 0001104659-25-071779 001-39231 251162724 34 194498 1 1
2025-07-24 4 xslF345X05/ownership.xml 0000902664-25-003152 12455
2025-07-24 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000947871-25-000684 005-91451 251148033 34 27663
2025-07-21 144 xsl144X01/primary_doc.xml 0000947871-25-000679 001-39231 251138173 33 14470
2025-07-21 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000947871-25-000678 005-91451 251138150 34 27821
2025-07-15 144 xsl144X01/primary_doc.xml 0000947871-25-000667 001-39231 251126019 33 13817
2025-07-14 8-K FORM 8-K 3.03,5.03,8.01,9.01 0001104659-25-067561 001-39231 251120121 34 231086 1 1
2025-07-09 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000947871-25-000657 005-91451 251114619 34 27227
2025-07-07 144 xsl144X01/primary_doc.xml 0000947871-25-000648 001-39231 251109136 33 11166
2025-06-26 4 xslF345X05/ownership.xml 0000947871-25-000629 11532
2025-06-24 144 xsl144X01/primary_doc.xml 0000947871-25-000628 001-39231 251070464 33 8678
2025-06-23 8-K FORM 8-K 8.01,9.01 0001104659-25-061371 001-39231 251062944 34 6604800 1 1
2025-05-30 4 xslF345X05/form4-05312025_010556.xml 0001415889-25-015077 12063
2025-05-30 4 xslF345X05/form4-05302025_110508.xml 0001415889-25-015059 11935
2025-05-30 4 xslF345X05/form4-05302025_110515.xml 0001415889-25-015058 12114
2025-05-30 4 xslF345X05/form4-05302025_110521.xml 0001415889-25-015057 12100
2025-05-30 4 xslF345X05/form4-05302025_110532.xml 0001415889-25-015056 12064
2025-05-30 4 xslF345X05/form4-05302025_110538.xml 0001415889-25-015055 12090
2025-05-30 4 xslF345X05/form4-05302025_110528.xml 0001415889-25-015054 5608
2025-05-30 8-K FORM 8-K 5.07 0001104659-25-054907 001-39231 251011362 34 205376 1 1
2025-05-13 10-Q 10-Q 0001558370-25-007489 001-39231 25937119 34 6965209 1 1
2025-05-13 8-K 8-K 2.02,7.01,9.01 0001558370-25-007487 001-39231 25937076 34 6600090 1 1
2025-04-25 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000947871-25-000425 005-91451 25875677 34 27035
2025-04-24 4 xslF345X05/ownership.xml 0000947871-25-000423 11527
2025-04-17 4 xslF345X05/ownership.xml 0000947871-25-000415 11527
2025-04-16 ARS ARS 0001558370-25-004879 001-39231 25841202 34 8337546
2025-04-16 DEFA14A DEFA14A 0001558370-25-004878 001-39231 25841199 34 374126
2025-04-16 DEF 14A DEF 14A 0001558370-25-004877 001-39231 25841195 34 1585550 1 1
2025-04-15 144 xsl144X01/primary_doc.xml 0000947871-25-000393 001-39231 25840749 33 4977
2025-04-04 PRE 14A PRE 14A 0001558370-25-004441 001-39231 25812047 34 1517425 1 1
2025-03-18 4 xslF345X05/form4-03182025_090317.xml 0001415889-25-008443 5560
2025-03-18 4 xslF345X05/form4-03182025_090335.xml 0001415889-25-008442 5543
2025-03-18 4 xslF345X05/form4-03182025_090302.xml 0001415889-25-008441 5573
2025-03-05 424B5 424B5 0001104659-25-020562 333-277632 25708637 33 45114
2025-03-05 S-8 FORM S-8 0001104659-25-020555 333-285549 25708611 33 95380
2025-03-04 10-K 10-K 0001558370-25-002101 001-39231 25701536 34 10406457 1 1
2025-03-04 8-K 8-K 2.02,7.01,9.01 0001558370-25-002093 001-39231 25701477 34 6567691 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-000982 005-91451 25623717 34 10528
2025-02-12 4 xslF345X05/form4-02122025_090233.xml 0001415889-25-003728 9933
2025-01-31 8-K FORM 8-K 3.01 0001104659-25-008100 001-39231 25578401 34 205802 1 1
2025-01-14 4 xslF345X05/ownership.xml 0000947871-25-000034 12933
2025-01-10 8-K FORM 8-K 2.02,2.05,2.06,7.01,8.01,9.01 0001104659-25-002278 001-39231 25520340 34 280594 1 1
2025-01-08 4 xslF345X05/ownership.xml 0000947871-25-000021 12932
2025-01-06 144 xsl144X01/primary_doc.xml 0000947871-25-000010 001-39231 25512042 33 8686
2024-12-31 4 xslF345X05/ownership.xml 0000902664-24-007075 7871
2024-12-26 4 xslF345X05/ownership.xml 0000947871-24-001037 8163
2024-12-26 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000947871-24-001036 005-91451 241581410 34 31163
2024-12-11 4 xslF345X05/ownership.xml 0000947871-24-000998 12466
2024-12-06 4 xslF345X05/ownership.xml 0000947871-24-000995 10781
2024-12-04 144 xsl144X01/primary_doc.xml 0000947871-24-000981 001-39231 241527401 33 7593
2024-12-04 144 xsl144X01/primary_doc.xml 0000947871-24-000980 001-39231 241527391 33 7478
2024-11-27 4 xslF345X05/ownership.xml 0000902664-24-006799 12232
2024-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001398344-24-020926 005-91451 241464405 34 6788
2024-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001398344-24-020911 005-91451 241464002 34 6595
2024-11-14 SC 13G PASSAGE BIO, INC. 0000902664-24-006563 005-91451 241459142 34 67279
2024-11-13 10-Q 10-Q 0001558370-24-015431 001-39231 241451162 34 11672903 1 1
2024-11-13 8-K 8-K 2.02,7.01,9.01 0001558370-24-015429 001-39231 241451114 34 6428207 1 1
2024-10-24 8-K 8-K 7.01,9.01 0001558370-24-013563 001-39231 241390676 34 3987776 1 1
2024-10-02 4 xslF345X05/form4-10022024_081040.xml 0001415889-24-024433 5553
2024-10-02 4 xslF345X05/form4-10022024_081016.xml 0001415889-24-024416 5561
2024-10-02 3 xslF345X02/form3-10022024_081024.xml 0001415889-24-024408 9644
2024-09-23 4 xslF345X05/ownership.xml 0000947871-24-000769 8628
2024-09-18 4 xslF345X05/ownership.xml 0000947871-24-000763 12469
2024-09-16 144 xsl144X01/primary_doc.xml 0000947871-24-000760 001-39231 241302318 33 4858
2024-09-16 144 xsl144X01/primary_doc.xml 0000947871-24-000759 001-39231 241302316 33 4951
2024-09-16 8-K 8-K 7.01,8.01,9.01 0001558370-24-012793 001-39231 241299298 34 7036879 1 1
2024-09-10 8-K FORM 8-K 5.02 0001104659-24-098371 001-39231 241288729 34 206998 1 1
2024-09-06 8-K 8-K 2.06 0001558370-24-012654 001-39231 241284684 34 162446 1 1
2024-08-09 SC 13D/A SC 13D/A 0001193125-24-198056 005-91451 241194339 34 66790
2024-08-09 SC 13G/A PASSAGE BIO, INC. 0000902664-24-005050 005-91451 241193987 34 62882
2024-08-09 3 xslF345X02/ownership.xml 0000902664-24-005049 6395
2024-08-08 10-Q 10-Q 0001558370-24-011463 001-39231 241186026 34 7486432 1 1
2024-08-08 8-K 8-K 2.02,7.01,9.01 0001558370-24-011459 001-39231 241185939 34 6540718 1 1
2024-08-02 8-K FORM 8-K 3.01 0001104659-24-085360 001-39231 241170972 34 205186 1 1
2024-08-01 8-K FORM 8-K 1.01,2.02,5.02,7.01,9.01 0001104659-24-084615 001-39231 241164156 34 255779 1 1
2024-07-16 8-K 8-K 7.01,8.01,9.01 0001558370-24-009826 001-39231 241118578 34 205971 1 1
2024-05-29 SC 13D/A SC 13D/A 0001193125-24-149241 005-91451 24999058 34 113635
2024-05-23 4 xslF345X05/form4-05232024_090550.xml 0001415889-24-014333 5606
2024-05-23 4 xslF345X05/form4-05232024_080547.xml 0001415889-24-014313 5443
2024-05-23 4 xslF345X05/form4-05232024_080500.xml 0001415889-24-014312 5567
2024-05-23 4 xslF345X05/form4-05232024_080531.xml 0001415889-24-014311 5574
2024-05-23 4 xslF345X05/form4-05232024_080524.xml 0001415889-24-014310 5591
2024-05-23 4 xslF345X05/form4-05232024_080531.xml 0001415889-24-014309 5604
2024-05-22 8-K FORM 8-K 5.07 0001104659-24-064243 001-39231 24973197 34 212332 1 1
2024-05-14 424B3 424B3 0001104659-24-060899 333-277632 24941544 33 456116
2024-05-14 10-Q 10-Q 0001558370-24-008058 001-39231 24941442 34 6836192 1 1
2024-05-14 8-K 8-K 2.02,7.01,9.01 0001558370-24-008054 001-39231 24941418 34 6819365 1 1
2024-04-16 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-04-16 16:00:00 9999999995-24-000982 333-277632 24849288 33 1815
2024-04-12 CORRESP filename1.htm 0001104659-24-046858 11397
2024-04-12 SC 13D/A AMENDMENT NO. 4 0000947871-24-000373 005-91451 24842545 34 114737
2024-04-09 DEFA14A DEFA14A 0001104659-24-045039 001-39231 24831395 34 848083
2024-04-09 DEF 14A DEF 14A 0001104659-24-044915 001-39231 24831048 34 1066723
2024-04-09 ARS ARS 0001104659-24-044912 001-39231 24831043 34 3927119
2024-03-29 SC 13G PASSAGE BIO, INC. 0000902664-24-002687 005-91451 24804272 34 65844
2024-03-19 4 xslF345X05/form4-03192024_080352.xml 0001415889-24-008495 5554
2024-03-19 4 xslF345X05/form4-03192024_080347.xml 0001415889-24-008491 5562
2024-03-19 4 xslF345X05/form4-03192024_080351.xml 0001415889-24-008489 5555
2024-03-19 4 xslF345X05/form4-03192024_080350.xml 0001415889-24-008487 5549
2024-03-07 UPLOAD filename1.pdf 0000000000-24-002537 333-277632 40397
2024-03-04 S-8 FORM S-8 0001104659-24-030519 333-277637 24715906 33 98127
2024-03-04 S-3 S-3 0001104659-24-030481 333-277632 24715043 33 1022119
2024-03-04 10-K 10-K 0001558370-24-002310 001-39231 24712831 34 10676466 1 1
2024-03-04 8-K 8-K 2.02,5.02,7.01,9.01 0001558370-24-002309 001-39231 24712819 34 6611402 1 1
2024-02-29 8-K FORM 8-K 8.01 0001104659-24-029361 001-39231 24703590 34 201803 1 1
2024-02-14 SC 13G/A PASSAGE BIO, INC. 0000902664-24-001612 005-91451 24633038 34 64996
2024-02-13 4 xslF345X05/form4-02142024_120246.xml 0001415889-24-003640 9097
2024-02-13 4 xslF345X05/form4-02142024_120249.xml 0001415889-24-003637 15977
2024-01-05 8-K 8-K 7.01,9.01 0001558370-24-000107 001-39231 24516261 34 6337532 1 1
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000369 9650
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000367 9615
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000365 9658
2023-12-29 8-K FORM 8-K 8.01,9.01 0001104659-23-130478 001-39231 231527845 34 305277 1 1
2023-12-20 8-K FORM 8-K 8.01,9.01 0001104659-23-127507 001-39231 231499364 34 274365 1 1
2023-11-13 10-Q 10-Q 0001558370-23-018686 001-39231 231395068 34 7251322 1 1
2023-11-13 8-K 8-K 2.02,7.01,9.01 0001558370-23-018679 001-39231 231394996 34 6998903 1 1
2023-11-09 SC 13D/A SC 13D/A 0001193125-23-274641 005-91451 231393926 34 120679
2023-09-01 8-K FORM 8-K 3.01 0001104659-23-097755 001-39231 231232622 34 204010 1 1
2023-08-07 10-Q 10-Q 0001558370-23-013489 001-39231 231145575 34 6662157 1 1
2023-08-07 8-K 8-K 2.02,7.01,8.01,9.01 0001558370-23-013486 001-39231 231145570 34 4726397 1 1
2023-08-01 4 FORM 4 SUBMISSION 0001209191-23-043998 9247
2023-07-31 4 FORM 4 SUBMISSION 0001209191-23-043872 5512
2023-07-31 3 FORM 3 SUBMISSION 0001209191-23-043861 6676
2023-07-31 8-K FORM 8-K 5.02 0001104659-23-085580 001-39231 231125022 34 206577 1 1
2023-07-28 4 FORM 4 SUBMISSION 0001209191-23-043725 5581
2023-07-28 3 FORM 3 SUBMISSION 0001209191-23-043724 13490
2023-07-20 8-K FORM_8K 5.02,8.01 0001104659-23-082546 001-39231 231098058 34 209737 1 1
2023-06-29 4 xslF345X04/ownership.xml 0000947871-23-000712 9736
2023-06-29 SC 13D/A AMENDMENT NO. 3 0000947871-23-000711 005-91451 231057928 34 113717
2023-06-20 4 FORM 4 SUBMISSION 0001209191-23-038345 9458
2023-06-15 SC 13D/A SC 13D/A 0001193125-23-167517 005-91451 231016244 34 121249
2023-05-26 4 FORM 4 SUBMISSION 0001209191-23-032571 5482
2023-05-26 4 FORM 4 SUBMISSION 0001209191-23-032568 5531
2023-05-26 4 FORM 4 SUBMISSION 0001209191-23-032565 5494
2023-05-26 4 FORM 4 SUBMISSION 0001209191-23-032552 5515
2023-05-26 8-K FORM 8-K 5.07 0001104659-23-065493 001-39231 23969390 34 214357 1 1
2023-05-26 4 FORM 4 SUBMISSION 0001209191-23-032546 5501
2023-05-26 4 FORM 4 SUBMISSION 0001209191-23-032545 5350
2023-05-26 4 FORM 4 SUBMISSION 0001209191-23-032542 5533
2023-05-11 10-Q 10-Q 0001558370-23-009256 001-39231 23908787 34 6311894 1 1
2023-05-11 8-K 8-K 2.02,7.01,9.01 0001558370-23-009253 001-39231 23908776 34 7748662 1 1
2023-04-20 4 FORM 4 SUBMISSION 0001209191-23-024982 9427
2023-04-14 ARS ARS 0001104659-23-045309 001-39231 23819731 34 52023699
2023-04-14 DEFA14A DEFA14A 0001104659-23-045308 001-39231 23819729 34 383940
2023-04-14 DEF 14A DEF 14A 0001104659-23-045305 001-39231 23819727 34 874201
2023-04-06 8-K 8-K 1.01 0001558370-23-005571 001-39231 23806560 34 165982 1 1
2023-04-05 4 FORM 4 SUBMISSION 0001209191-23-023481 5528
2023-04-05 4 FORM 4 SUBMISSION 0001209191-23-023479 5532
2023-04-05 4 FORM 4 SUBMISSION 0001209191-23-023478 5534
2023-04-05 4 FORM 4 SUBMISSION 0001209191-23-023477 5521
2023-04-05 4 FORM 4 SUBMISSION 0001209191-23-023476 5550
2023-04-03 PRE 14A PRE 14A 0001104659-23-040826 001-39231 23792611 34 900416
2023-03-10 8-K FORM 8-K 7.01 0001104659-23-031221 001-39231 23724292 34 202749 1 1
2023-03-06 S-8 FORM S-8 0001104659-23-028902 333-270293 23708357 33 397233
2023-03-06 10-K 10-K 0001558370-23-002833 001-39231 23707538 34 9338883 1 1
2023-03-06 8-K 8-K 2.02,7.01,9.01 0001558370-23-002831 001-39231 23707517 34 7587789 1 1
2023-02-24 8-K 8-K 7.01,9.01 0001558370-23-001964 001-39231 23662309 34 3205407 1 1
2023-02-14 SC 13G/A PASSAGE BIO, INC. 0000902664-23-001802 005-91451 23629037 34 66450
2023-02-14 SC 13G/A deeptrack-pasg123122a2.htm 0001172661-23-000850 005-91451 23623065 34 102980
2023-01-09 8-K 8-K 2.02,7.01,9.01 0001558370-23-000123 001-39231 23516512 34 7186906 1 1
2022-12-14 8-K 8-K 7.01,9.01 0001558370-22-018617 001-39231 221461120 34 4883512 1 1
2022-12-02 4 FORM 4 SUBMISSION 0001209191-22-059462 5236
2022-12-02 8-K FORM 8-K 5.03,9.01 0001104659-22-124102 001-39231 221442099 34 471801 1 1
2022-11-25 4 FORM 4 SUBMISSION 0001209191-22-058795 10063
2022-11-18 4 FORM 4 SUBMISSION 0001209191-22-057891 9373
2022-11-14 4 FORM 4 SUBMISSION 0001209191-22-056614 5624
2022-11-14 4 FORM 4 SUBMISSION 0001209191-22-056613 5626
2022-11-14 4 FORM 4 SUBMISSION 0001209191-22-056611 5613
2022-11-14 4 FORM 4 SUBMISSION 0001209191-22-056609 5642
2022-11-10 10-Q 10-Q 0001558370-22-017285 001-39231 221374919 34 6981400 1 1
2022-11-10 8-K 8-K 2.02,5.02,7.01,9.01 0001558370-22-017280 001-39231 221374863 34 6096544 1 1
2022-10-12 4 FORM 4 SUBMISSION 0001209191-22-053454 5547
2022-10-12 3 FORM 3 SUBMISSION 0001209191-22-053453 6744
2022-10-11 8-K FORM 8-K 5.02 0001104659-22-107408 001-39231 221302313 34 209511 1 1
2022-09-29 SC 13G PASSAGE BIO, INC. 0000902664-22-004380 005-91451 221280931 34 68856
2022-08-15 SC 13D/A SC 13D/A 0001193125-22-220875 005-91451 221163666 34 132882
2022-08-11 8-K FORM 8-K 8.01 0001104659-22-088998 001-39231 221153653 34 199968 1 1
2022-08-04 8-K 8-K 2.02,7.01,9.01 0001558370-22-012048 001-39231 221134669 34 7626258 1 1
2022-08-04 10-Q 10-Q 0001558370-22-012042 001-39231 221134657 34 6944164 1 1
2022-07-08 SC 13G us7027121000_070822.txt 0000834237-22-010173 005-91451 221074961 34 12390
2022-07-06 4 FORM 4 SUBMISSION 0001209191-22-041401 5421
2022-07-06 3 FORM 3 SUBMISSION 0001209191-22-041400 6680
2022-07-06 8-K 8-K 5.02 0001558370-22-010548 001-39231 221067377 34 157943 1 1
2022-06-15 4 FORM 4 SUBMISSION 0001209191-22-037060 5519
2022-06-15 4 FORM 4 SUBMISSION 0001209191-22-037054 5500
2022-06-15 4 FORM 4 SUBMISSION 0001209191-22-037053 5504
2022-06-15 4 FORM 4 SUBMISSION 0001209191-22-037051 5493
2022-06-15 4 FORM 4 SUBMISSION 0001209191-22-037050 5518
2022-06-08 8-K FORM 8-K 8.01 0001104659-22-069166 001-39231 221002595 34 201993 1 1
2022-06-01 4 FORM 4 SUBMISSION 0001209191-22-033163 5263
2022-06-01 4 FORM 4 SUBMISSION 0001209191-22-033158 5440
2022-06-01 4 FORM 4 SUBMISSION 0001209191-22-033149 5490
2022-06-01 8-K FORM 8-K 5.02,5.07 0001104659-22-066896 001-39231 22986007 34 222985 1 1
2022-05-31 4 FORM 4 SUBMISSION 0001209191-22-032839 5450
2022-05-31 4 FORM 4 SUBMISSION 0001209191-22-032837 5499
2022-05-31 4 FORM 4 SUBMISSION 0001209191-22-032825 5462
2022-05-31 4 FORM 4 SUBMISSION 0001209191-22-032819 5469
2022-05-31 4 FORM 4 SUBMISSION 0001209191-22-032812 5318
2022-05-31 4 FORM 4 SUBMISSION 0001209191-22-032807 5501
2022-05-18 8-K 8-K 7.01,8.01,9.01 0001558370-22-009142 001-39231 22937034 34 3735306 1 1
2022-05-16 10-Q 10-Q 0001558370-22-008859 001-39231 22925466 34 6582625 1 1
2022-05-16 8-K 8-K 2.02,7.01,9.01 0001558370-22-008854 001-39231 22925420 34 7374979 1 1
2022-05-05 4 xslF345X03/ownership.xml 0000947871-22-000509 10372
2022-05-05 4/A xslF345X03/ownership.xml 0000947871-22-000507 8776
2022-05-05 SC 13D/A AMENDMENT NO. 2 0000947871-22-000506 005-91451 22897381 34 122217
2022-04-20 4 FORM 4 SUBMISSION 0001209191-22-024942 5703
2022-04-20 4 FORM 4 SUBMISSION 0001209191-22-024938 5547
2022-04-14 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001558370-22-002827,2022-04-14 9999999995-22-000975 333-253955 22828884 33 1779
2022-04-14 DEFA14A DEFA14A 0001104659-22-046032 001-39231 22827453 34 354665
2022-04-14 DEF 14A DEF 14A 0001104659-22-046024 001-39231 22827419 34 673406
2022-04-08 3 FORM 3 SUBMISSION 0001209191-22-023926 6746
2022-03-23 4 FORM 4 SUBMISSION 0001209191-22-020791 8352
2022-03-15 8-K FORM 8-K 8.01 0001104659-22-033615 001-39231 22739099 34 201208 1 1
2022-03-11 8-K FORM 8-K 5.02 0001104659-22-032947 001-39231 22733907 34 201329 1 1
2022-03-10 8-K FORM 8-K 8.01 0001104659-22-032216 001-39231 22727382 34 200801 1 1
2022-03-03 POS AM POS AM 0001558370-22-002827 333-253955 22710217 33 118513
2022-03-03 S-8 S-8 0001558370-22-002743 333-263252 22706858 33 177132
2022-03-03 POS AM POS AM 0001558370-22-002736 333-253955 22706816 33 697749
2022-03-03 10-K 10-K 0001558370-22-002719 001-39231 22706747 34 8828585 1 1
2022-03-03 8-K 8-K 2.02,9.01 0001558370-22-002717 001-39231 22706733 34 304616 1 1
2022-03-03 POSASR POSASR 0001558370-22-002714 333-253955 22706708 33 792007
2022-02-14 4 PRIMARY DOCUMENT 0001787297-22-000006 5432
2022-02-14 4 PRIMARY DOCUMENT 0001787297-22-000005 9150
2022-02-14 4 PRIMARY DOCUMENT 0001787297-22-000004 10042
2022-02-14 4 PRIMARY DOCUMENT 0001787297-22-000003 5415
2022-02-14 4 PRIMARY DOCUMENT 0001787297-22-000002 5429
2022-02-14 4 PRIMARY DOCUMENT 0001787297-22-000001 6245
2022-02-14 SC 13G/A deeptrack-pasg123121a1.htm 0001172661-22-000424 005-91451 22625847 34 103061
2022-02-14 SC 13G/A SC 13G/A 0001193125-22-039332 005-91451 22625079 34 92358
2022-02-11 8-K 8-K 7.01,8.01,9.01 0001558370-22-001039 001-39231 22617709 34 4753059 1 1
2022-02-09 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-22-006086 005-91451 22605334 34 93092
2022-02-04 SC 13G us7027121000_020422.txt 0000834237-22-007116 005-91451 22593336 34 13443
2022-01-24 4 xslF345X03/ownership.xml 0000947871-22-000090 8157
2022-01-20 4 xslF345X03/ownership.xml 0000947871-22-000086 11815
2022-01-13 4 xslF345X03/ownership.xml 0000947871-22-000055 11815
2022-01-10 8-K 8-K 2.02,7.01,8.01,9.01 0001558370-22-000157 001-39231 22519742 34 6607776 1 1
2021-12-17 8-K 8-K 7.01,8.01,9.01 0001558370-21-016900 001-39231 211499469 34 4125603 1 1
2021-12-10 4 FORM 4 SUBMISSION 0001209191-21-069101 10791
2021-12-10 SC 13G/A filing.txt 0000315066-21-001899 005-91451 211483778 34 8590
2021-11-04 10-Q 10-Q 0001558370-21-014460 001-39231 211378118 34 6692364 1 1
2021-11-04 8-K 8-K 2.02,7.01,9.01 0001558370-21-014458 001-39231 211378082 34 7517770 1 1
2021-11-01 8-K 8-K 5.02 0001558370-21-013927 001-39231 211368014 34 157141 1 1
2021-10-25 SC 13G deeptrack-pasg102221.htm 0001172661-21-002057 005-91451 211344978 34 102980
2021-10-04 8-K 8-K 7.01,9.01 0001558370-21-012944 001-39231 211301013 34 7300116 1 1
2021-08-25 4 FORM 4 SUBMISSION 0001209191-21-053365 5580
2021-08-25 3 FORM 3 SUBMISSION 0001209191-21-053363 6733
2021-08-05 10-Q 10-Q 0001558370-21-010405 001-39231 211146402 34 6443215 1 1
2021-08-05 8-K 8-K 2.02,7.01,9.01 0001558370-21-010372 001-39231 211146232 34 2733493
2021-07-21 4 FORM 4 SUBMISSION 0001209191-21-047616 8232
2021-07-21 3 FORM 3 SUBMISSION 0001209191-21-047615 6742
2021-07-21 8-K 8-K 5.02 0001558370-21-009027 001-39231 211102754 34 35142
2021-07-19 S-8 S-8 0001558370-21-008991 333-258000 211096885 33 476146
2021-06-09 3 FORM 3 SUBMISSION 0001209191-21-039270 9323
2021-06-01 4 FORM 4 SUBMISSION 0001209191-21-036754 5263
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036630 5398
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036629 5417
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036628 5417
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036625 5410
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036622 5437
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036621 5427
2021-05-28 3 FORM 3 SUBMISSION 0001209191-21-036618 6656
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036616 5449
2021-05-28 8-K 8-K 5.07 0001558370-21-007852 001-39231 21979967 34 39945
2021-05-21 4 FORM 4 SUBMISSION 0001209191-21-035059 4808
2021-05-21 4 FORM 4 SUBMISSION 0001209191-21-035051 4852
2021-05-19 4 FORM 4 SUBMISSION 0001209191-21-034185 5726
2021-05-18 8-K FORM 8-K 5.02 0001104659-21-068911 001-39231 21936945 34 23334
2021-05-05 10-Q 10-Q 0001558370-21-005807 001-39231 21891234 34 5523252 1
2021-05-05 8-K 8-K 2.02,7.01,9.01 0001558370-21-005788 001-39231 21891111 34 7730004
2021-04-14 DEFA14A DEFA14A 0001558370-21-004269 001-39231 21825781 34 295680
2021-04-14 DEF 14A DEF 14A 0001558370-21-004266 001-39231 21825694 34 902582
2021-03-29 4 FORM 4 SUBMISSION 0001209191-21-023476 10593
2021-03-29 3 FORM 3 SUBMISSION 0001209191-21-023475 6763
2021-03-22 8-K 8-K 5.02,8.01 0001558370-21-003287 001-39231 21759870 34 32252
2021-03-17 4 FORM 4 SUBMISSION 0001209191-21-021616 15332
2021-03-05 S-3ASR S-3ASR 0001104659-21-032832 333-253955 21719642 33 1308049
2021-03-05 S-8 S-8 0001558370-21-002454 333-253922 21718431 33 171774
2021-03-03 10-K 10-K 0001558370-21-002287 001-39231 21707267 34 8630289 1
2021-03-03 8-K 8-K 2.02,7.01,9.01 0001558370-21-002283 001-39231 21707198 34 7509041
2021-02-22 4 FORM 4 SUBMISSION 0001209191-21-012828 9024
2021-02-22 3 FORM 3 SUBMISSION 0001209191-21-012825 6591
2021-02-19 8-K 8-K 5.02 0001558370-21-001301 001-39231 21656916 34 40264
2021-02-18 4 FORM 4 SUBMISSION 0001209191-21-012170 5542
2021-02-18 4 FORM 4 SUBMISSION 0001209191-21-012169 6351
2021-02-18 4 FORM 4 SUBMISSION 0001209191-21-012160 5532
2021-02-18 4 FORM 4 SUBMISSION 0001209191-21-012158 6370
2021-02-18 4 FORM 4 SUBMISSION 0001209191-21-012156 6399
2021-02-18 4 FORM 4 SUBMISSION 0001209191-21-012154 6401
2021-02-17 8-K 8-K 5.02 0001558370-21-001151 001-39231 21645795 34 40113
2021-02-12 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-21-009004 005-91451 21628151 34 79697
2021-02-11 SC 13G SC 13G 0001193125-21-038695 005-91451 21620756 34 117865
2021-02-09 SC 13G SCHEDULE 13G 0001213900-21-007749 005-91451 21606761 34 95638
2021-02-08 SC 13G/A filing.txt 0000315066-21-001195 005-91451 21599742 34 8423
2021-01-28 SC 13D/A AMENDMENT NO. 1 0000947871-21-000111 005-91451 21563950 34 142557
2021-01-27 SC 13D/A SC 13D/A 0001193125-21-019026 005-91451 21559256 34 99160
2021-01-22 4 FORM 4 SUBMISSION 0001209191-21-004949 6319
2021-01-22 424B1 424B1 0001104659-21-006683 333-252213 21546182 33 10892689
2021-01-21 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-01-21 16:30:00 9999999995-21-000233 333-252213 21543667 33 1766
2021-01-19 CORRESP filename1.htm 0001104659-21-005394 13433
2021-01-19 CORRESP filename1.htm 0001104659-21-005393 12964
2021-01-19 S-1 S-1 0001104659-21-005296 333-252213 21535459 33 20041394 1
2021-01-15 4 FORM 4 SUBMISSION 0001209191-21-003921 10250
2021-01-11 8-K FORM 8-K 7.01,9.01 0001104659-21-002688 001-39231 21519112 34 8502201
2020-12-22 UPLOAD filename1.pdf 0000000000-20-012344 40615
2020-12-18 DRS filename1.htm 0001104659-20-137415 377-03911 201400662 33 11443410
2020-12-18 8-K FORM 8-K 1.01,9.01 0001104659-20-137129 001-39231 201397990 34 435935
2020-11-10 10-Q 10-Q 0001558370-20-013472 001-39231 201299672 34 5660360 1
2020-11-10 8-K 8-K 2.02,9.01 0001558370-20-013468 001-39231 201299590 34 214703
2020-09-09 8-K FORM 8-K 7.01,9.01 0001104659-20-103244 001-39231 201165374 34 3864253
2020-08-13 10-Q 10-Q 0001558370-20-010495 001-39231 201097290 34 4878850 1
2020-08-13 8-K FORM 8-K 2.02,9.01 0001104659-20-094318 001-39231 201097196 34 107859
2020-06-10 SC 13G filing.txt 0000315066-20-001577 005-91451 20953727 34 8473
2020-05-11 10-Q 10-Q 0001558370-20-006239 001-39231 20864785 34 6181259 1
2020-05-11 8-K FORM 8-K 2.02,9.01 0001104659-20-059108 001-39231 20862620 34 99739
2020-05-07 8-K FORM 8K 1.01 0001104659-20-057763 001-39231 20854640 34 20527
2020-04-14 8-K FORM 8-K 1.01 0001104659-20-046098 001-39231 20789988 34 28079
2020-04-03 8-K FORM 8-K 7.01,8.01 0001104659-20-042697 001-39231 20771590 34 58622
2020-03-27 8-K FORM 8-K 5.03,9.01 0001104659-20-039591 001-39231 20751796 34 206785
2020-03-25 4 FORM 4 SUBMISSION 0001209191-20-021188 5017
2020-03-13 4/A FORM 4/A SUBMISSION 0001209191-20-018974 11417
2020-03-13 SC 13D SC 13D 0001104659-20-033184 005-91451 20713528 34 289066
2020-03-12 3/A FORM 3/A SUBMISSION 0001209191-20-018632 5259
2020-03-12 SC 13G SC 13G 0001193125-20-071355 005-91451 20707969 34 106027
2020-03-09 SC 13D SCHEDULE 13D 0001193125-20-067330 005-91451 20698868 34 155851
2020-03-09 SC 13D SCHEDULE 13D 0000947871-20-000199 005-91451 20698601 34 117289
2020-03-06 SC 13G SCHEDULE 13G 0001213900-20-005616 005-91451 20695173 34 115438
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015675 19646
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015670 28391
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015666 21807
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015661 19170
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015654 18040
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015648 4550
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015640 4568
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015634 6581
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015629 4564
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015628 4539
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015626 4543
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015623 4642
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015621 4651
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015619 4583
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015618 4630
2020-03-02 4 FORM 4 SUBMISSION 0001209191-20-014706 5515
2020-03-02 4 FORM 4 SUBMISSION 0001209191-20-014704 5479
2020-03-02 4 FORM 4 SUBMISSION 0001209191-20-014702 5459
2020-03-02 4 FORM 4 SUBMISSION 0001209191-20-014700 5498

Latest XBRL company facts

One latest value per concept from companyfacts (212 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 3.22M 2026-11-06 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
dei EntityNumberOfEmployees Entity Number of Employees employee 27 2024-01-31 2024 FY 10-K 2025-03-04 0001558370-25-002101
dei EntityPublicFloat Entity Public Float USD 25.40M 2025-06-30 2025 FY 10-K 2026-03-03 0001104659-26-022549
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 618,347 2025-01-01 2025-12-31 DEF 14A 2026-04-07 0001104659-26-040130
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 722,565 2025-01-01 2025-12-31 DEF 14A 2026-04-07 0001104659-26-040130
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 1.53M 2025-01-01 2025-12-31 DEF 14A 2026-04-07 0001104659-26-040130
ecd PeoTotalCompAmt PeoTotalCompAmt USD 1.49M 2025-01-01 2025-12-31 DEF 14A 2026-04-07 0001104659-26-040130
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 58 2025-01-01 2025-12-31 DEF 14A 2026-04-07 0001104659-26-040130
ffd NetFeeAmt NetFeeAmt USD 1.29 2026-09-03 S-4/A 2026-09-03 0001140361-26-035517
ffd TtlFeeAmt TtlFeeAmt USD 2.43 2026-09-03 S-4/A 2026-09-03 0001140361-26-035517
ffd TtlOfferingAmt TtlOfferingAmt USD 17,521.98 2026-09-03 S-4/A 2026-09-03 0001140361-26-035517
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-03 S-4/A 2026-09-03 0001140361-26-035517
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 1.14 2026-09-03 S-4/A 2026-09-03 0001140361-26-035517
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 533,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 2.28M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 3.92M 2025-12-31 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 8,000 2024-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 724.91M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 1.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 129,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 524,265 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 2.64M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap Assets Assets USD 20.79M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap AssetsCurrent Assets, Current USD 20.79M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 9,000 2024-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 1,000 2024-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 39.17M 2024-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 7.34M 2023-12-31 2023 FY 10-K 2024-03-04 0001558370-24-002310
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 7.30M 2023-12-31 2023 FY 10-K 2024-03-04 0001558370-24-002310
us-gaap AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value USD 39.18M 2024-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002101
us-gaap AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost USD 39.17M 2024-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002101
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 39.17M 2024-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002101
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 39.18M 2024-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002101
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 39.18M 2024-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 20.16M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 46.30M 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 20.16M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -26.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 46.30M 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 3.22M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 3.22M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap CommonStockValue Common Stock, Value, Issued USD 6,000 2025-03-31 2025 Q1 10-Q 2025-05-13 0001558370-25-007489
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -20.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 17.03M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 3.04M 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 200,000 2020-12-31 2020 FY 10-K 2021-03-03 0001558370-21-002287
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 3.20M 2022-01-01 2022 FY 10-K 2023-03-06 0001558370-23-002833
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 225.80M 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 55.02M 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 3.04M 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 105.42M 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 4.33M 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 222.75M 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 336,000 2023-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002101
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 154,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -6.26 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -2.53 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001558370-21-014460
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -6.26 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.272 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.14 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002101
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0.086 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002101
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.025 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 241,000 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.005 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.025 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002101
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.004 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 788,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 1.20M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 2.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 15.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 3.37M 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 3.50M 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 12.33M 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -9.56M 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 4,000 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.16M 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 175,000 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD -580,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 3.87M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-13 0001558370-20-010495
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -693,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 2.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -356,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-03 0001558370-21-002287
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001558370-22-008859
us-gaap InvestmentIncomeNet Investment Income, Net USD 2.27M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001558370-23-002833
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 800,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap LeaseCost Lease, Cost USD 1.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 37.30M 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 17.42M 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 3.76M 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 4.20M 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 4.08M 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 3.97M 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 3.86M 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 900,000 2026-03-31 S-4 2026-07-21 0001140361-26-029162
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 13.29M 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap Liabilities Liabilities USD 20.74M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 20.79M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap LiabilitiesCurrent Liabilities, Current USD 20.74M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap LitigationReserveCurrent Estimated Litigation Liability, Current USD 1.00M 2024-09-30 2024 Q3 10-Q 2024-11-13 0001558370-24-015431
us-gaap LongTermPurchaseCommitmentAmount Long-term Purchase Commitment, Amount USD 2.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -8,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 14,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 23,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -26.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -20.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-04 0001558370-24-002310
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -21.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap OperatingLeaseCost Operating Lease, Cost USD 581,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 2.50M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001558370-23-018686
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 24.01M 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 3.57M 2025-12-31 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 20.44M 2025-12-31 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap OperatingLeasePaymentsUse Operating Lease, Payments, Use USD 800,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 10.17M 2025-12-31 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 139,000 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap OtherAssetsFairValueDisclosure Other Assets, Fair Value Disclosure USD 139,000 2025-12-31 2025 FY 10-K 2026-03-03 0001104659-26-022549
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 244,000 2025-12-31 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax USD -5,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-05 0001558370-21-005807
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax USD -8,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 2.00M 2023-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002101
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 2.00M 2023-03-31 2023 Q1 10-Q 2023-05-11 0001558370-23-009256
us-gaap OtherNoncashExpense Other Noncash Expense USD 14,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 1.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 4.64M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001558370-23-018686
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 763,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-03 0001558370-21-002287
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 338,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-06 0001558370-23-002833
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-04 0001558370-24-002310
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 3.00M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-04 0001558370-24-002310
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD 34,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002101
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 88.17M 2024-01-01 2024-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 34,000 2024-01-01 2024-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 517,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 3.37M 2021-03-31 2021 Q1 10-Q 2021-05-05 0001558370-21-005807
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 165.81M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-06 0001558370-23-002833
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 8.74M 2024-01-01 2024-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 39.05M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 23,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 1.17M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001104659-25-109180
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 35,000 2024-01-01 2024-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 14,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 8.02M 2025-12-31 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 4.11M 2025-12-31 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap PurchaseCommitmentRemainingMinimumAmountCommitted Purchase Commitment, Remaining Minimum Amount Committed USD 10.60M 2020-04-30 2020 Q3 10-Q 2020-11-10 0001558370-20-013472
us-gaap ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff Research and Development Asset Acquired Other than Through Business Combination, Written-off USD 3.00M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-04 0001558370-24-002310
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 8.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 30.62M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001558370-24-015431
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -724.86M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 422,000 2024-01-01 2024-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.937 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.041 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 200,000 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 322,561 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 36.65 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 200,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001558370-23-002833
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 197,998 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 206,454 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 4.94M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002101
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 254,744 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 5.31 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 302,277 2020-12-31 2021 FY 10-K 2022-03-03 0001558370-22-002719
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 509,265 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 26.56 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 1.04M 2020-12-31 2020 FY 10-K 2021-03-03 0001558370-21-002287
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 7.49 2020-12-31 2020 FY 10-K 2021-03-03 0001558370-21-002287
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 509,265 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 26.56 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 302,277 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-03 0001558370-22-002719
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.08 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002101
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 75.82 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 11.49 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 7 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 50,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.05 2025-07-14 S-4/A 2026-09-03 0001140361-26-035517
us-gaap StockIssuedDuringPeriodSharesReverseStockSplits Stock Issued During Period, Shares, Reverse Stock Splits shares 0 2025-07-14 S-4/A 2026-09-03 0001140361-26-035517
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 14,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 8.74M 2024-01-01 2024-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 35,000 2024-01-01 2024-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 81,000 2021-01-01 2021-03-31 2022 Q1 10-Q 2022-05-16 0001558370-22-008859
us-gaap SubleaseIncome Sublease Income USD 620,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 230.60M 2019-12-31 2020 FY 10-K 2021-03-03 0001558370-21-002287
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 2.90M 2025-01-01 2025-12-31 S-4/A 2026-09-03 0001140361-26-035517
us-gaap VariableLeaseCost Variable Lease, Cost USD 504,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 3.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 53.08M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001558370-21-014460
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 3.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124783

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →